IGM Biosciences Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) Transcript
All right. Hello, and welcome. My name is Michael Schmidt. I am a biotech analyst with Guggenheim Securities. And it is my great pleasure to welcome the next company, IGM Biosciences. With us today, we have Fred Schwarzer, CEO; Chris Takimoto, Chief Medical Officer; as well as Bruce Keyt, Chief Scientific Officer.
Welcome, guys, and thank you so much for joining us.
Thanks very much for having us, Michael, and appreciate the opportunity.
Yeah. And I think you'd like to start out with a couple slides and some opening statements. So please, go ahead.
Yeah. If you don't mind, I'd love to show a few slides here with some interesting -- some data, some new data. I think you'll find it interesting, or at least, I hope you'll find it interesting. So let me try to share my screen here.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
